secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2022-06-14T23:59:59+00:00
Accession:  0001564590-22-023139
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology presents updated corporate deck at Goldman Sachs conference
------------------------------------------------------------------------------

- Company discussed updated corporate presentation at Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022.
- No specific financial or pipeline data disclosed in the filing; presentation content not fully reproduced.
- Filing is a routine Reg FD disclosure; no material changes to previously announced information evident.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000156459022023139/0001564590-22-023139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000156459022023139/sana-8k_20220614.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-023139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer